Threshold Pharmaceuticals (THLD) earns a $20M milestone payment from Merck KGaA (MKGAF.PK). The...

|About: Threshold Pharmaceuticals... (THLD)|By:, SA News Editor

Threshold Pharmaceuticals (THLD) earns a $20M milestone payment from Merck KGaA (MKGAF.PK). The payment was tied to performance of its TH-302 pancreatic cancer treatment candidate in a Phase 2 trial.